BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17062977)

  • 1. Differential myolysis of myocardium and skeletal muscle in hamsters with dilated cardiomyopathy: beneficial protective effect of diltiazem.
    Kato Y; Iwase M; Takagi K; Nishizawa T; Kanazawa H; Matsushita A; Umeda H; Izawa H; Noda A; Koike Y; Nagata K; Yokota M
    Circ J; 2006 Nov; 70(11):1497-502. PubMed ID: 17062977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial alterations of beta-adrenergic signaling in dilated cardiomyopathic hamsters: possible role of myocardial oxidative stress.
    Nishizawa T; Iwase M; Kanazawa H; Ichihara S; Ichihara G; Nagata K; Obata K; Kitaichi K; Yokoi T; Watanabe M; Tsunematsu T; Ishikawa Y; Murohara T; Yokota M
    Circ J; 2004 Nov; 68(11):1051-60. PubMed ID: 15502388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of growth hormone-releasing peptide on myocardial oxidative stress and left ventricular dysfunction in dilated cardiomyopathic hamsters.
    Kato Y; Iwase M; Ichihara S; Kanazawa H; Hashimoto K; Noda A; Nagata K; Koike Y; Yokota M
    Circ J; 2010 Jan; 74(1):163-70. PubMed ID: 19942785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.
    Sabharwal R; Chapleau MW
    Exp Physiol; 2014 Apr; 99(4):627-31. PubMed ID: 24334334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters.
    Iwase M; Kanazawa H; Kato Y; Nishizawa T; Somura F; Ishiki R; Nagata K; Hashimoto K; Takagi K; Izawa H; Yokota M
    Cardiovasc Res; 2004 Jan; 61(1):30-8. PubMed ID: 14732199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of membrane-mediated chronic muscle degeneration in dystrophic hamsters by calcium-channel blockers: diltiazem, nifedipine and verapamil.
    Johnson PL; Bhattacharya SK
    J Neurol Sci; 1993 Mar; 115(1):76-90. PubMed ID: 8468595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer.
    Zhu T; Zhou L; Mori S; Wang Z; McTiernan CF; Qiao C; Chen C; Wang DW; Li J; Xiao X
    Circulation; 2005 Oct; 112(17):2650-9. PubMed ID: 16230483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
    Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
    Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorating effects of amlodipine on plasma and myocardial catecholamines in BIO 53.58 Syrian hamsters, a model of dilated cardiomyopathy.
    Yamada S; Urayama A; Kimura R; Watanabe H; Ohashi K
    Life Sci; 2000 Nov; 67(25):3051-9. PubMed ID: 11125842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: effects on left ventricular geometry and function.
    Ohno N; Fedak PW; Weisel RD; Mickle DA; Fujii T; Li RK
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1537-48. PubMed ID: 14666030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells.
    Iwata Y; Katanosaka Y; Shijun Z; Kobayashi Y; Hanada H; Shigekawa M; Wakabayashi S
    Biochem Pharmacol; 2005 Sep; 70(5):740-51. PubMed ID: 16009351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?
    Pouly J; Hagège AA; Vilquin JT; Bissery A; Rouche A; Bruneval P; Duboc D; Desnos M; Fiszman M; Fromes Y; Menasché P
    Circulation; 2004 Sep; 110(12):1626-31. PubMed ID: 15364802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
    Hirata Y; Soeki T; Akaike M; Sakai Y; Igarashi T; Sata M
    Biomed Pharmacother; 2009 Dec; 63(10):781-6. PubMed ID: 19906506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of enzyme activities in the myocardium and skeletal muscle fibres of cardiomyopathic hamsters. A cytophotometrical study.
    Punkt K; Erzen I
    Exp Toxicol Pathol; 2000 May; 52(2):103-10. PubMed ID: 10965983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of induced hyperthyroidism in normal and cardiomyopathic hamsters.
    Kuzman JA; Thomas TA; Vogelsang KA; Said S; Anderson BE; Gerdes AM
    J Appl Physiol (1985); 2005 Oct; 99(4):1428-33. PubMed ID: 15976357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: calcineurin/PP2B activity in the heart of J2N-k hamster.
    Mitsuhashi S; Saito N; Watano K; Igarashi K; Tagami S; Shima H; Kikuchi K
    J Biochem; 2003 Aug; 134(2):269-76. PubMed ID: 12966077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of extracellular matrix in dilated cardiomyopathic hamster heart.
    Okada H; Kawaguchi H; Kudo T; Sawa H; Okamoto H; Watanabe S; Urasawa K; Murakami T; Kitabatake A
    Mol Cell Biochem; 1996 Mar; 156(1):9-15. PubMed ID: 8709981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and oncosis in the early progression of left ventricular dysfunction in the cardiomyopathic hamster.
    Ryoke T; Gu Y; Ikeda Y; Martone ME; Oh SS; Jeon ES; Knowlton KU; Ross J
    Basic Res Cardiol; 2002 Jan; 97(1):65-75. PubMed ID: 12004790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier.
    Barison A; Aquaro GD; Passino C; Falorni M; Balbarini A; Lombardi M; Pasquali L; Emdin M; Siciliano G
    J Neurol; 2009 Feb; 256(2):283-4. PubMed ID: 19253058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.